Author | Weiyun Z. Ai, MD, PhD | OncLive

Author | Weiyun Z. Ai, MD, PhD

Articles

Dr. Ai on the Efficacy of Brentuximab Vedotin in Patients With Advanced CTCL

February 12, 2018

Video

Weiyun Z. Ai, MD, PhD, assistant clinical professor, Department of Medicine, University of California San Francisco, discusses the scenarios in which she has seen the most benefit from brentuximab vedotin (Adcetris) in patients with advanced stage cutaneous T-cell lymphoma.

Dr. Ai on Potential With Mogamulizumab in CTCL

January 23, 2018

Video

Weiyun Z. Ai, MD, PhD, assistant clinical professor, Department of Medicine, University of California San Francisco, speaks to the relevance of mogamulizumab (Poteligeo) in treating Sezary syndrome, a rare and aggressive form of cutaneous T-cell lymphoma

x